2024-12-13FDA approves cosibelimab-ipdl for metastatic or locally advanced cutaneous squamous cell carcinomaDrug Unloxcyt (cosibelimab-ipdl) · Anti-PD-L1 antibodyConditionDermatologic
2020-07-30FDA approves atezolizumab for BRAF V600 unresectable or metastatic melanomaDrugs Tecentriq (atezolizumab) · Anti-PD-L1 antibody, cobimetinib · MEK inhibitor, vemurafenib · BRAF inhibitorConditionDermatologic